About Factor Bioscience
Factor Bioscience is a company based in Cambridge (United States) founded in 2011 by Christopher Rohde. Factor Bioscience has raised $1 million across 4 funding rounds from investors including HHS and SBIR. Factor Bioscience operates in a competitive market with competitors including Senti Biosciences, Arbor Biotechnologies, Tenaya Therapeutics, Singleron and Bluebird Bio, among others.
- Headquarter Cambridge, United States
- Founders Christopher Rohde
- SectorsHealthcare
- Email••••••••
- Website factor.bio
- Social LinkedIn X
- Total Equity Funding$1M (USD)
in 4 rounds
- Latest Funding Round$1M (USD), Seed
Sep 2025
- InvestorsHHS
& 1 more
Funding Insights of Factor Bioscience
Factor Bioscience has successfully raised a total of $1M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $1 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1M
- Total Rounds 4
- Last Round Seed — $1M
- First Round $150,000
(Sep 2012)
- Investors Count 2
All 4 funding rounds of Factor Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Factor Bioscience
Factor Bioscience has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and SBIR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Federal innovation and scientific achievement services are provided. | 1982 | sbir.gov | Lithia Springs, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Factor Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Factor Bioscience
2 people are tracked at Factor Bioscience (2 in leadership).
| Name | Role | Group |
|---|---|---|
Christopher Rohde | Co-Founder & CTO | Leadership |
Matt Angel | Co-Founder, Chairman & CEO | Leadership |
Complete people profiles for Factor Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Factor Bioscience
3 dated milestones of Factor Bioscience across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Factor Bioscience is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Seed, of $1.0M.
Competitors of Factor Bioscience
Factor Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Arbor Biotechnologies, Tenaya Therapeutics, Singleron and Bluebird Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sentibio.com | 2016 | San Francisco, United States | $158M | – | Cell-based therapies for cancer treatment are developed. | |
| arbor.bio | 2016 | Cambridge, United States | $304.1M | 117 | Genomic technologies and drug discovery platforms are provided. | |
| tenayatherapeutics.com | 2016 | San Francisco, United States | $142M | 140 | Regenerative and gene therapeutics for heart failure are developed. | |
| singleron.bio | 2018 | Hagen, Germany | $84.48M | – | Developer of single-cell multi-omics platform for clinical research and molecular diagnosis | |
| bluebirdbio.com | 1992 | Cambridge, United States | $210.68M | 508 | Gene therapies for severe genetic and rare diseases are developed. | |
| jaspertx.com | 1999 | Redwood, United States | $84.1M | – | Developer of therapeutics for chronic diseases by targeting mast cells and stem cells | |
| tunetx.com | 2009 | Seattle, United States | $222.41M | – | Cell and gene therapies are developed via an epigenomic platform. | |
| ringtx.com | 2018 | Cambridge, United States | $203.5M | 117 | Gene therapy platform developed via human commensal virome. | |
| octant.bio | 2017 | Los Angeles, United States | $110M | 63 | Human cell interaction platform is provided for drug discovery. |
Detailed competitors of Factor Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Factor Bioscience
The website of Factor Bioscience (factor.bio) receives about 2.5K visits a month.
- Monthly visits2.5K
▼ 22.9% vs previous month
Latest news on Factor Bioscience
Complete news archive for Factor Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Factor Bioscience
10 companies that operate in the same segment as Factor Bioscience (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Factor Bioscience
Factor Bioscience was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Factor Bioscience is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Factor Bioscience is a funded company, having raised a total of $1M across 4 funding rounds to date. The company's 1st funding round was a Grant of $150K, raised on Sep 2012.
Factor Bioscience was founded in 2011 in Cambridge, United States, within the biotechnology sector. Gene-editing and cell-reprogramming technologies are utilized to generate clonal lines of pluripotent stem cells and advance regenerative cell therapies. Disease-focused approaches are applied to address cancer, genetic disorders, infectious conditions, and degenerative diseases through targeted treatments. Operations emphasize innovation in genomic applications for health improvement.
Factor Bioscience's top competitors include Senti Biosciences, Arbor Biotechnologies and Tenaya Therapeutics.